Diabetes and brain health
Published: May 21, 2020
Insulin signalling is essential for brain health, and people with diabetes are at increased risk of cognitive impairment and dementia. The prevention and treatment of diabetes could therefore reduce the incidence of cognitive impairment. A joint Series between The Lancet Neurology and The Lancet Diabetes & Endocrinology covers current advances on diabetes and brain health, aiming to shed light on the complex interplay between the central nervous system and peripheral insulin regulation, on screening and prognostication of people at risk of cognitive dysfunction, on early diagnosis, and novel therapeutic approaches, particularly in relation to type-2 diabetes.
Neurological disorders in China
The Lancet Neurology
Published: April 30, 2019
China is the most populated country in the world, and the one with the most patients with neurological disorders. Neurological research in China can speed up advances that will benefit patients elsewhere. This Series provides an unprecedented description of the clinical and public-health challenges caused by the most prevalent neurological diseases in China. Local experts suggest research priorities and call for international collaborations through which China might prove its scientific strength.
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
The Lancet Neurology
Published: November 6, 2017
Traumatic brain injury (TBI) is a public health challenge of vast, but insufficiently recognised, proportions. TBI is the leading cause of mortality in young adults and a major cause of death and disability across all ages in all countries. In high-income countries, the number of elderly people with TBI is increasing, mainly due to falls, while in low-income and middle-income countries, the burden of TBI from road traffic incidents is increasing.
Defeating Alzheimer's disease and other dementias
The Lancet Neurology
Published: March 15, 2016
The prevalence of Alzheimer’s disease (AD) and other age-related dementias is increasing dramatically with ageing populations worldwide. No treatment is yet available to halt or reverse the underlying pathology of established AD—the most common cause of dementia—and the economic and societal burdens of dementia threaten to become overwhelming as more people live into old age.